Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe

被引：0
|
作者：
Lehne, Moritz [1 ]
Kortuem, K. Martin [2 ]
Zamagni, Elena [3 ]
d'Estrube, Tim [4 ]
Shukla, Soham [5 ]
Zhuleku, Evi [1 ]
Ghiani, Marco [6 ]
Hanna, Maya [5 ]
Maywald, Ulf [7 ]
Wilke, Thomas [6 ]
Perera, Sue [4 ]
机构：
[1] Cytel Inc, Berlin, Germany
[2] Univ Klinikum Wurzburg, Wurzburg, Germany
[3] Univ Bologna, Bologna, Italy
[4] GSK, London, England
[5] GSK, Upper Providence, PA USA
[6] Inst Pharmakookon & Arzneimittellogist eV, Wismar, Germany
[7] AOK PLUS, Dresden, Germany
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-163586
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：12485 / 12486
页数：2
相关论文
共 50 条
  • [1] Real-world treatment patterns in patients initiating third-line therapy for relapsed or refractory multiple myeloma in Germany, Italy, the United Kingdom, France, and Spain
    Lehne, Moritz
    Kortum, K. Martin
    Ramasamy, Karthik
    Zamagni, Elena
    d'Estrube, Tim
    Zhuleku, Evi
    Hanna, Maya
    Shukla, Soham
    Ghiani, Marco
    Maywald, Ulf
    Wilke, Thomas
    Kellermann, Lenka
    Perera, Sue
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 701 - 713
  • [2] Standards of Care and Treatment Patterns Among Relapsed/Refractory Multiple Myeloma Patients Initiating Second- and Third-Line Therapies
    Boytsov, Natalie
    Gorsh, Boris
    Anderson, Seth
    Wang, Peter Feng
    Perera, Sue
    Franklin, Meg
    [J]. BLOOD, 2022, 140 : 12554 - 12555
  • [3] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [4] Treatment Patterns Among Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Secondand Third-Line Therapy in a Medicare Population
    Tkacz, Joseph
    Gorsh, Boris
    Molinari, Alexa
    Boytsov, Natalie
    Wang, Peter Feng
    Perera, Sue
    Landi, Suzanne
    Hanna, Maya
    Johnson, William
    Schroeder, Amy
    Paka, Prani
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S423 - S423
  • [5] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [6] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [7] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [9] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [10] Bortezomib therapy in a real-world setting in patients with relapsed or refractory multiple myeloma
    Huang, Shang-Yi
    Chen, Tsai-Yun
    Kuo, Ching-Yuan
    Chen, Yeu-Chin
    Lin, Sheng-Fung
    Chang, Ming-Chih
    Lv, Xinzhu
    Yang, Betty
    Chang, Cheng-Shyong
    [J]. ONCOLOGY REVIEWS, 2019, 13 (01) : 15 - 22
12345